Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q62447

Entry ID Method Resolution Chain Position Source
AF-Q62447-F1 Predicted AlphaFoldDB

9 variants for Q62447

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388678589 70 K>M No EVA
rs1133362340 139 E>K No EVA
rs3388673370 202 L>P No EVA
rs3388674688 225 E>G No EVA
rs3388672550 234 I>N No EVA
rs3388672174 235 L>* No EVA
rs3388672652 235 L>I No EVA
rs3388672652 235 L>V No EVA
rs3388677976 238 Y>* No EVA

No associated diseases with Q62447

3 regional properties for Q62447

Type Name Position InterPro Accession
domain Cyclin, N-terminal 37 - 148 IPR006671
domain Cyclin-like domain 46 - 144 IPR013763-1
domain Cyclin-like domain 157 - 236 IPR013763-2

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cyclin-dependent protein kinase holoenzyme complex Cyclin-dependent protein kinases (CDKs) are enzyme complexes that contain a kinase catalytic subunit associated with a regulatory cyclin partner.
mediator complex A protein complex that interacts with the carboxy-terminal domain of the largest subunit of RNA polymerase II and plays an active role in transducing the signal from a transcription factor to the transcriptional machinery. The mediator complex is required for activation of transcription of most protein-coding genes, but can also act as a transcriptional corepressor. The Saccharomyces complex contains several identifiable subcomplexes: a head domain comprising Srb2, -4, and -5, Med6, -8, and -11, and Rox3 proteins; a middle domain comprising Med1, -4, and -7, Nut1 and -2, Cse2, Rgr1, Soh1, and Srb7 proteins; a tail consisting of Gal11p, Med2p, Pgd1p, and Sin4p; and a regulatory subcomplex comprising Ssn2, -3, and -8, and Srb8 proteins. Metazoan mediator complexes have similar modular structures and include homologs of yeast Srb and Med proteins.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
ubiquitin ligase complex A protein complex that includes a ubiquitin-protein ligase and enables ubiquitin protein ligase activity. The complex also contains other proteins that may confer substrate specificity on the complex.

3 GO annotations of molecular function

Name Definition
cyclin-dependent protein serine/threonine kinase regulator activity Modulates the activity of a cyclin-dependent protein serine/threonine kinase, enzymes of the protein kinase family that are regulated through association with cyclins and other proteins.
identical protein binding Binding to an identical protein or proteins.
ubiquitin protein ligase activity Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S -> X + S-ubiquitin, where X is either an E2 or E3 enzyme, the X-ubiquitin linkage is a thioester bond, and the S-ubiquitin linkage is an amide bond: an isopeptide bond between the C-terminal glycine of ubiquitin and the epsilon-amino group of lysine residues in the substrate or, in the linear extension of ubiquitin chains, a peptide bond the between the C-terminal glycine and N-terminal methionine of ubiquitin residues.

6 GO annotations of biological process

Name Definition
G0 to G1 transition The mitotic cell cycle phase transition whose occurrence commits the cell from the G0 quiescent state to the G1 phase. Under certain conditions, cells exit the cell cycle during G1 and remain in the G0 state as nongrowing, non-dividing (quiescent) cells. Appropriate stimulation of such cells induces them to return to G1 and resume growth and division. The G0 to G1 transition is accompanied by many changes in the program of gene expression.
negative regulation of Notch signaling pathway Any process that stops, prevents, or reduces the frequency, rate or extent of the Notch signaling pathway.
negative regulation of triglyceride metabolic process Any process that decreases the frequency, rate or extent of the chemical reactions and pathways involving triglyceride, any triester of glycerol.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
protein ubiquitination The process in which one or more ubiquitin groups are added to a protein.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.

10 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P47821 SSN8 RNA polymerase II holoenzyme cyclin-like subunit Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q3ZCK5 CCNC Cyclin-C Bos taurus (Bovine) PR
P55168 CCNC Cyclin-C Gallus gallus (Chicken) PR
P25008 CycC Cyclin-C Drosophila melanogaster (Fruit fly) PR
P24863 CCNC Cyclin-C Homo sapiens (Human) PR
Q61458 Ccnh Cyclin-H Mus musculus (Mouse) PR
Q9QWV9 Ccnt1 Cyclin-T1 Mus musculus (Mouse) SS
O88874 Ccnk Cyclin-K Mus musculus (Mouse) PR
P39947 Ccnc Cyclin-C Rattus norvegicus (Rat) PR
Q28F72 ccnc Cyclin-C Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MAGNFWQSSH YLQWILDKQD LLKERQKDLK FLSEEEYWKL QIFFTNVIQA LGEHLKLRQQ
70 80 90 100 110 120
VIATATVYFK RFYARYSLKS IDPVLMAPTC VFLASKVEEF GVVSNTRLIA ATTSVLKTRF
130 140 150 160 170 180
SYAFPKEFPY RMNHILECEF YLLELMDCCL IVYHPYRPLL QYVQDMGQED VLLPLAWRIV
190 200 210 220 230 240
NDTYRTDLCL LYPPFMIALA CLHVACVVQQ KDARQWFAEL SVDMEKILEI IRVILKLYEQ
250 260 270 280
WKNFDERKEM ATILSKMPKP KPPPNSEGEQ GPNGSQNSSY SQS